Download Print VersionNeed help? Email us or call 919-549-8880.
Results
Your search returned 168 companies:
| APP Pharmaceuticals LLC | APP Pharmaceuticals, Inc (APP) is engaged in developing, manufacturing and marketing injectable pharmaceutical products with a focus on injectable critical care, anti-infective and oncology markets. | Raleigh |
| Abraxis BioScience Inc. | Abraxis BioScience is a biotechnology company dedicated to delivering therapeutics and core technologies that offer patients and medical professionals treatments for cancer and other critical illnesses. | Durham |
| Actavis U.S. | Actavis manufactures OTC and prescription creams, ointments, liquids, and suppository products at its facility in Lincolnton. Products include hydrocortisone, anti-fungal, and permethrin products. | Lincolnton |
| Adherex Technologies Inc. | Adherex is developing novel therapeutics to address the unmet medical needs of cancer patients. Specifically, the company is developing product candidates from its portfolio of cell adhesion and cell signaling molecules, known as cadherins. | Durham |
| Adroit Pharmaceutical Development LLC | Adroit Pharmaceutical Development identifies new formulations and process technologies. Adroit also identifies and corrects problems with existing formulations and processes. Adroit's primary focus is on inhalation and dermatological product development. | Durham |
| Aerie Pharmaceuticals | Aerie Pharmaceuticals is developing new therapies for sight-threatening diseases of the eye. The company is developing a product that specifically targets the diseased tissue that underlies glaucoma. | Research Triangle Park |
| Affinergy Inc. | Affinergy is developing a range of products that address musculoskeletal conditions that impair mobility and quality of life for patients. | Research Triangle Park |
| Agarigen Inc. | Agarigen is engaged in the development of novel biopharmaceutical expression and processing technology. The company is developing technology to manufacture commercially valuable proteins using mushrooms. | Research Triangle Park |
| Agile Sciences Inc. | Agile Sciences has identified novel small molecules that inhibit and disperse bacterial biofilms. The company is investigating multiple applications in medicine, agriculture, and industry. | Raleigh |
| Alaeras Inc. | Alaeras specializes in design and manufacturing of drug delivery products. The company is currently developing a platform technology for dry powder nasal vaccines that do not require refrigeration. | Cary |
| Algynomics Inc. | Algynomics is developing and marketing genetic markers in the field of pain. The company is developing medical devices that integrate information of genetic pain biomarkers with neurological and psychological assessments. | Durham |
| AlphaVax Inc. | AlphaVax is a clinical-stage company focused on developing new vaccine products for infectious diseases, biodefense and cancer. The AlphaVax in-house product pipeline includes products for Herpes Simplex virus, influenza and Respiratory Syncytial Virus. | Research Triangle Park |
| Alphavax Inc. (Lenoir) | AlphaVax's GMP manufacturing facility in Lenoir is leased from Greer Laboratories. The vaccine production facility is a BSL-3. | Lenoir |
| Alte Biosciences Inc. | Alte Biosciences is a drug delivery-based therapeutics company that commercializes technologies to enhance the safety and performance of proprietary drug products. | Cary |
| Amorsus Pharma LLC | Amorsus Pharma is developing a sustained release product incorporating both bupivacaine and dexamethasone for use following tooth extraction to provide patients with prolonged anesthesia to reduce intra-operative and post procedure pain. | Raleigh |
| Apex Bioscience Inc. | Apex Bioscience is a wholly-owned US subsidiary of Curacyte AG, a German research-based biopharmaceutical company dedicated to the discovery and development of hospital therapeutics for acute and critical care conditions. | Chapel Hill |
| Applied Pharma Research | Applied Pharma Research provides R&D and contract development work for oral, transdermal and topical drug delivery technologies. The Charlotte site is the US headquarters and business development office. | Charlotte |
| Arbor Pharmaceuticals Inc. | Arbor Pharmaceuticals licenses, develops and commercializes novel prescription pharmaceutical brands for significant pediatric conditions including ear infections and dermatitis. | Raleigh |
| Arbovax Inc. | Arbovax Inc. is an early stage company focused on commercialization of a novel technology to develop improved vaccines to prevent arthropod-borne diseases. | Raleigh |
| Argos Therapeutics Inc. | Argos Therapeutics is an immunotherapy company developing new treatments for cancer, infectious and autoimmune diseases, and transplantation rejection. | Durham |
Need help? Email us or call 919-549-8880.
The North Carolina Biotechnology Center strives to provide accurate and current data on the bioscience community in North Carolina. You may reproduce the site content for any legal purpose with proper attribution. Attribution shall take the following form: "Data provided by the North Carolina Biotechnology Center, www.ncbiotech.org."